Tuesday, February 28, 2023 Daily Archives

PackGene building $20m AAV plant in Texas

by

CDMO PackGene has broken ground on a facility in Houston set to offer customers adeno-associated virus (AAV) vector development and manufacturing services. The 25,000 square-foot expansion in Houston, Texas – expected to be completed by the end of the year at a cost of around $20 million – will offer PackGene Biotech’s US customer scalable AAV products, along with viral vector development and GMP production capabilities. The facility will include process and analytical laboratories, cGMP manufacturing cleanrooms and support areas,…

February 28, 2023

Internal and external investment to grow Moderna beyond COVID

by

Moderna has set out its capital allocation priorities under the shadow of overcapacity and lower COVID vaccine demand. Moderna’s Q4 saw revenues from its COVID-19 messenger RNA (mRNA) vaccine of $4.8 billion, down 30% on the same period 2021. For the full year 2023, Moderna has forecasted just $5 billion in COVID sales from advanced purchase agreements and deferrals – a fraction of the $18.4 billion the vaccine made in 2022. The plummeting in sales relates to the continued return…

February 28, 2023